Germany

Alex Rogers is an American medical cannabis business owner and founder of the International Cannabis Business Conference.

With cannabis reforms gaining traction around the world, most predict Germany to be the next major legalization victory — the question is will that happen in 2023, or beyond?

Coming off the heels of a very big year for cannabis, what does 2023 have in store for the emerging international industry?

Germany this week announced its plans for adult-use cannabis legalization including possession limitations and home grow provisions.

The German government has outlined its plan to legalize adult-use cannabis nationally including provisions allowing for possession of up to 20 grams and homegrow of up to two plants.

Lawmakers from Germany recently toured California cannabis businesses and spoke with advocates, regulators, and industry experts about lessons learned when creating a legal industry.

Niklas “Nik” Kouparanis is CEO, Co-Founder, and Board Member at The Bloomwell Group, a cannabis brand ecosphere based in Germany.

Materia Malta, a leading medical cannabis distributor in Europe, has shipped Malta’s first international cannabis export to Germany.

Germany started holding expert hearings this week related to its cannabis legalization plan, which lawmakers expect to finalize by the end of the year.

Germany’s Health Minister Karl Lauterbach said he will begin preparations for setting up an adult-use cannabis market in the country.

Germany’s incoming coalition government is set to legalize adult-use cannabis nationwide and license dispensaries to conduct regulated sales.

Cannabis legalization in Germany could be worth around 3.4 billion euros in tax revenues and about 1.3 billion euros in cost savings.

German police unions voiced opposition to national cannabis legalization following election victories by Social Democrats, the Greens, and the Free Democrats, all of which support the reforms.

The German state of Baden-Württemberg is funding hemp supplier Signature Products with close to €800,000 for the development of a regional hemp protein value chain.

Canada’s MediPharm and European pharmaceutical firm STADA have signed an exclusive supply agreement for the distribution of medical cannabis products in Germany.

Following an official inquiry by opposition lawmakers in the Free Democratic Party, federal officials in Germany said they anticipate another six-month delay in the licensing of medical cannabis businesses.